| First Author | Mann H | Year | 1997 |
| Journal | Brain Res | Volume | 769 |
| Issue | 2 | Pages | 340-6 |
| PubMed ID | 9374204 | Mgi Jnum | J:44568 |
| Mgi Id | MGI:1100452 | Doi | 10.1016/s0006-8993(97)00754-3 |
| Citation | Mann H, et al. (1997) Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice. Brain Res 769(2):340-6 |
| abstractText | The toxic effects of methamphetamine (METH) (2.5, 5.0 and 10.0 mg/kg) and methylenedioxymethamphetamine (MDMA) (5.0, 10.0 and 20.0 mg/kg) on dopaminergic systems were assessed in the striatum and of the nucleus accumbens in mdr1a wild- type and knockout mice. METH caused significant dose- dependent decreases of dopamine (DA) and DA transporters (DAT) in the striatum and the nucleus accumbens (NAc) of both wild-type and knockout mice. The lowest doses of METH (2.5 mg/kg) caused only small changes in the wild-type, but marked decreases in the mdr1a knockout mice. The two higher doses (5 mg/kg and 10 mg/kg) caused similar changes in both strains of mice. In contrast to METH, MDMA caused greater percentage decreases in DAT in the wild-type mice. For example, the lowest dose (5 mg/kg) caused significant decreases in DAT in the NAc of wild-type but not of mdr1a knockout mice. The highest dose (20 mg/kg) caused similar changes in both the strains. These results suggest that METH and MDMA interact differentially with P- glycoproteins. These observations document, for the first time, a role for these proteins in the entry of METH and MDMA into the brain via the blood-brain barrier, with P- glycoprotein possibly facilitating the entry of MDMA but interfering with that of METH into the brain. (C) 1997 Elsevier Science B.V. |
